梅毒相关肾病的临床病理谱与治疗反应:系统综述
该系统综述纳入1990年至2025年发表的78篇文献共99例血清学确诊的梅毒相关肾病患者,总结其临床病理特征、治疗及结局。中位年龄34岁,75%为男性,81%表现为肾病综合征,79%活检为膜性肾病,抗梅毒治疗后75%完全缓解、23%部分缓解。
要点
- 梅毒相关肾病最常见表现为膜性肾病伴肾病综合征。
- 抗梅毒治疗后多数患者肾脏参数改善,完全缓解率达75%。
- 部分病例需联合免疫抑制治疗,但证据主要来自个案报告。
核心结论
- 梅毒相关肾病最常见表现为膜性肾病伴肾病综合征,抗梅毒治疗后通常改善。
主要发现
- 中位年龄34岁,75%为男性,非梅毒螺旋体抗体中位滴度类别为1:256。
- 81%患者出现肾病综合征,32%出现急性肾损伤。
- 活检诊断以膜性肾病最常见(79%),26%的活检病例报告满堂亮免疫荧光模式。
- 所有患者接受抗梅毒治疗,11%同时接受免疫抑制治疗;中位随访4周,完全缓解75%、部分缓解23%。
关键数值与推荐
- 抗梅毒治疗后肾脏参数普遍改善,完全缓解75%、部分缓解23%(中位随访4周)。
临床怎么用
- 对表现为肾病综合征的梅毒患者应考虑梅毒相关肾病,活检常见膜性肾病,首选抗梅毒治疗。
局限性
- 证据主要来自个案报告和病例系列,存在发表、报告、语言和数据库选择偏倚。
- 组织病理学和治疗疗程报告不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Syphilis-associated kidney disease is rare and most commonly occurs in active syphilis. This systematic review summarizes the clinicopathologic spectrum, treatment, and outcomes of syphilis-associated kidney disease. STUDY DESIGN: Systematic review of published case reports and case series. SETTING & STUDY POPULATIONS: Cases with serologically confirmed syphilis and kidney disease attributed to syphilis, reported between January 1990 and December 2025. SELECTION CRITERIA FOR STUDIES: PubMed and Web of Science were searched for case reports and case series with extractable individual-level data. Reports of congenital syphilis, conference abstracts, articles without full-text access, and cases lacking individual patient data were excluded. DATA EXTRACTION: Case-level data were extracted for demographics, the clinical presentation of syphilis, HIV status, serology findings, kidney manifestations including biopsy findings, treatment, kidney outcomes, and follow-up. ANALYTICAL APPROACH: Data were synthesized descriptively. Continuous variables were summarized as median and interquartile range, categorical variables as counts and percentages. Between-group and paired comparisons implemented using nonparametric or categorical tests, as appropriate. RESULTS: 99 cases from 78 publications were identified and included. Median age was 34 years, and 75% of patients were male. The median non-treponemal titer category was 1:256. Nephrotic syndrome occurred in 81% of patients and acute kidney injury in 32%. Membranous nephropathy was the most common biopsy diagnosis (79%), and a full-house immunofluorescence pattern was reported in 26% of biopsied cases. All patients received anti-syphilitic therapy, and 11% also received immunosuppressive therapy. Among patients with available outcome data, complete remission occurred in 75% and partial remission in 23%, with a median follow-up of 4 weeks. Kidney parameters generally improved after anti-syphilitic treatment. LIMITATIONS: Evidence was derived mainly from case reports and case series, with potential publication, reporting, language, and database-selection bias. Detailed histopathology and treatment duration were inconsistently reported. CONCLUSIONS: Syphilis-associated kidney disease most commonly presents as membranous nephropathy with nephrotic syndrome and usually improves after anti-syphilitic therapy. REGISTRATION: Registered at PROSPERO with identification number CRD420261322314.
引用
- Long X, Lin W, Liu D, et al. Clinicopathologic Spectrum and Treatment Response of Syphilis-Associated Kidney Disease: A Systematic Review. Am J Kidney Dis. 2026. PMID: 42966598. doi:10.1053/j.ajkd.2026.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。